Warfarin Sensitivity Test

Warfarin Sensitivity Test

Warfarin is a commonly prescribed oral anticoagulant drug, which reduces the tendency of blood to clot by disrupting the activity of an enzyme called vitamin K epoxide reductase that reactivates vitamin K1. Without sufficient active vitamin K1, clotting factors II, VII, IX, and X in the blood have decreased clotting ability.

Sensitivity to warfarin is very variable, with the drug dosage required to achieve the desired anticoagulant effect varying by up to 10-fold between individuals. Characterising warfarin sensitivity is particularly useful when commencing therapy as it enables clinical staff to prescribe the most suitable dosage of the drug, minimising the chances of harm occurring through inadvertant under- or over-dosing.

Warfarin sensitivity is determined partially by genetic factors, with polymorphisms in two genes (VKORC1 and CYP2C9) playing a particularly large role in determining each individual’s sensitivity to the drug.

Contact us

NewGene Limited
Bioscience Building
International Centre for Life
Newcastle upon Tyne
NE1 4EP, UK

Tel: +44 (0)191 242 1923
Fax: +44 (0)191 241 8799
Email: info@newgene.org.uk

Click here for location map

Mon – Fri 08:30 to 17:00, closed Bank Holidays

An ISO 15189 accredited Medical Laboratory company

NewGene Limited | Company Number: 06735445

Technology Partners

Agilent Technologies

Agena Bioscience

Illumina

Sophia Genetics

Qiagen

Promega

Enquiry form